Forte Biosciences is a biotechnology company that focuses on dermatology.
Forte Biosciences has raised $150.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Forte Biosciences's investors include Janus Henderson Investors, Perceptive Advisors, OrbiMed, Farallon Capital Management, Biotechnology Value Fund.
Forte Biosciences is headquartered in Sherman Oaks, United States.
Forte Biosciences is a biotechnology company that focuses on dermatology.
Forte Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Forte Biosciences — Funding & Investors." VCBacked, April 8, 2026, https://www.vcbacked.co/company/forte-biosciences. Accessed November 12, 2026.
VCBacked. (2026). Forte Biosciences — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/forte-biosciences
{{cite web |title=Forte Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/forte-biosciences |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Forte Biosciences? Request a listing update